Korea Joongang Daily on MSN1h
Celltrion's Actemra biosimilar gets FDA approval
Celltrion's biosimilar Avtozma, used to treat inflammatory diseases, was approved for the U.S. market by the Food and Drug Administration.
Daijiworld2h
Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatment
Celltrion, a major South Korean biopharmaceutical firm, on Friday said its new biosimilar for an autoimmune disease treatment has received approval from the US Food and Drug Administration (FDA). The ...